Literature DB >> 16557333

Indole-3-carbinol prevents PTEN loss in cervical cancer in vivo.

Mei Qi1, Ann E Anderson, Da-Zhi Chen, Shishinn Sun, Karen J Auborn.   

Abstract

Indole-3-carbinol (I3C) is a phytochemical (derived from broccoli, cabbage, and other cruciferous vegetables) with proven anticancer efficacy including the reduction of cervical intraepithelial neoplasia (CIN) and its progression to cervical cancer. In a breast cancer cell line, I3C inhibited cell adhesion, spreading, and invasion associated with an upregulation of the tumor suppressor gene PTEN, suggesting that PTEN is important in inhibition of late stages in the development of cancer. The goal of this study was to determine the expression of PTEN during the development of cervical cancer and whether I3C affected expression of PTEN in vivo. We show diminished PTEN expression during the progression from low-grade to high-grade cervical dysplasia in humans and in a mouse model for cervical cancer, the K14HPV16 transgenic mice promoted with estrogen. The implication is that loss of PTEN function is required for this transition. Additionally, dietary I3C increased PTEN expression in the cervical epithelium of the transgenic mouse, an observation that suggests PTEN upregulation by I3C is one mechanism by which I3C inhibits development of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16557333      PMCID: PMC1449523          DOI: 10.2119/2006-00007.Auborn

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  58 in total

1.  Ligand-independent activation of estrogen receptor function by 3, 3'-diindolylmethane in human breast cancer cells.

Authors:  J E Riby; G H Chang; G L Firestone; L F Bjeldanes
Journal:  Biochem Pharmacol       Date:  2000-07-15       Impact factor: 5.858

2.  Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN.

Authors:  N Nakamura; S Ramaswamy; F Vazquez; S Signoretti; M Loda; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  PTEN controls tumor-induced angiogenesis.

Authors:  S Wen; J Stolarov; M P Myers; J D Su; M H Wigler; N K Tonks; D L Durden
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

4.  Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells.

Authors:  Q Meng; I D Goldberg; E M Rosen; S Fan
Journal:  Breast Cancer Res Treat       Date:  2000-09       Impact factor: 4.872

5.  The synergistic upregulation of phase II detoxification enzymes by glucosinolate breakdown products in cruciferous vegetables.

Authors:  C W Nho; E Jeffery
Journal:  Toxicol Appl Pharmacol       Date:  2001-07-15       Impact factor: 4.219

6.  The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.

Authors:  Y Lu; Y Z Lin; R LaPushin; B Cuevas; X Fang; S X Yu; M A Davies; H Khan; T Furui; M Mao; R Zinner; M C Hung; P Steck; K Siminovitch; G B Mills
Journal:  Oncogene       Date:  1999-11-25       Impact factor: 9.867

7.  Phosphoinositide-dependent kinase-2 is a distinct protein kinase enriched in a novel cytoskeletal fraction associated with adipocyte plasma membranes.

Authors:  Richard C Hresko; Haruhiko Murata; Mike Mueckler
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

8.  Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter.

Authors:  E J Cram; B D Liu; L F Bjeldanes; G L Firestone
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

9.  PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma.

Authors:  H B Salvesen; N MacDonald; A Ryan; I J Jacobs; E D Lynch; L A Akslen; S Das
Journal:  Int J Cancer       Date:  2001-01-01       Impact factor: 7.396

10.  Placebo-controlled trial of indole-3-carbinol in the treatment of CIN.

Authors:  M C Bell; P Crowley-Nowick; H L Bradlow; D W Sepkovic; D Schmidt-Grimminger; P Howell; E J Mayeaux; A Tucker; E A Turbat-Herrera; J M Mathis
Journal:  Gynecol Oncol       Date:  2000-08       Impact factor: 5.482

View more
  7 in total

1.  Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.

Authors:  Lizhi He; Alistair Ingram; Adrian P Rybak; Damu Tang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells.

Authors:  Crystal N Marconett; Shyam N Sundar; Min Tseng; Antony S Tin; Kalvin Q Tran; Kelly M Mahuron; Leonard F Bjeldanes; Gary L Firestone
Journal:  Carcinogenesis       Date:  2011-06-21       Impact factor: 4.944

3.  Results from a dose-response study using 3,3'-diindolylmethane in the K14-HPV16 transgenic mouse model: cervical histology.

Authors:  Daniel W Sepkovic; Johann Stein; Antoine D Carlisle; H Barbara Ksieski; Karen Auborn; Laura Raucci; Themba Nyirenda; H Leon Bradlow
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-07

4.  Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model.

Authors:  Daniel W Sepkovic; Johann Stein; Antoine D Carlisle; H Barbara Ksieski; Karen Auborn; H Leon Bradlow
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-27       Impact factor: 4.254

5.  Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells.

Authors:  Yi Zhang; Fu-qiang Chen; Ye-hong Sun; Shu-yan Zhou; Ti-yuan Li; Rui Chen
Journal:  J Exp Clin Cancer Res       Date:  2011-10-17

Review 6.  Neuron membrane trafficking and protein kinases involved in autism and ADHD.

Authors:  Yasuko Kitagishi; Akari Minami; Atsuko Nakanishi; Yasunori Ogura; Satoru Matsuda
Journal:  Int J Mol Sci       Date:  2015-01-30       Impact factor: 5.923

Review 7.  Medical treatment of cervical intraepithelial neoplasia II, III: an update review.

Authors:  Chumnan Kietpeerakool; Jatupol Srisomboon
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.